FDA Brief

Warning letters Biologics

FDA warning letter to

Massachusetts Institute of Technology MIT

Issued Jun 21, 2024Posted Jul 16, 2024Center for Biologics Evaluation and Research (CBER)

Bioresearch Monitoring Program/IRB. We haven't summarized this letter yet. Read it on fda.gov.